Novofem (Estradiol | Norethisterone Acetate, Estradiol)

Estradiol and norethisterone acetate, the active ingredients in Novofem, are an estrogen‑progestogen combination presented as an oral tablet for systemic use. They are used to replace deficient hormones, helping to regulate the menstrual cycle and relieve menopausal symptoms in women.

GNH USA supplies Novofem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets through established distribution networks globally.

Novofem, an estrogen‑progestogen combination, is indicated for conditions related to hormonal deficiency and menopause. - Menopausal symptoms: alleviates hot flashes, night sweats, and vaginal dryness. - Estrogen deficiency: restores hormonal balance in women with low endogenous estrogen. - Hormone replacement therapy: provides combined estrogen and progestogen to prevent endometrial hyperplasia while treating menopausal signs.

Like all hormone therapies, Novofem may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: increased sensitivity or swelling. - Headache: transient cranial discomfort. - Irregular vaginal bleeding: spotting or breakthrough bleeding.

Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism. - Stroke or myocardial infarction: rare but potentially life‑threatening cardiovascular events. - Liver dysfunction: abnormal liver enzymes or cholestasis.

Before initiating Novofem, clinicians should evaluate individual risk factors and monitor patients regularly. - Cardiovascular risk assessment: evaluate history of thromboembolic disease before initiating therapy. - Breast cancer surveillance: monitor for new or worsening breast lesions during treatment. - Liver function monitoring: check hepatic enzymes periodically, especially in patients with pre‑existing liver disease. - Smoking status: avoid use in women over 35 who smoke due to increased clot risk. - Drug‑induced hormone sensitivity: discontinue if severe allergic reaction or hypersensitivity occurs. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Novofem can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Combined oral contraceptives: additive estrogen effect may increase thrombotic risk. - Anticoagulants (warfarin): estrogen component can potentiate anticoagulant effect, requiring INR monitoring. - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce plasma levels of norethisterone acetate, diminishing efficacy.

Moderate Interactions (Monitor Closely): - Antihypertensives: hormonal changes can affect blood pressure control. - Antidepressants (SSRIs/SNRIs): may alter vasomotor symptom relief. - Thyroid hormone replacement: estrogen can increase thyroid‑binding globulin, potentially requiring dose adjustment.